0
Skip to Content
SymbioCellTech
Home
Intellectual Property
Technology
Patent Portfolio
Publications
Species Specific Culture Medium
Pipeline
Company
Leadership
Board
Contact
News
SymbioCellTech
Home
Intellectual Property
Technology
Patent Portfolio
Publications
Species Specific Culture Medium
Pipeline
Company
Leadership
Board
Contact
News
Home
Folder: Intellectual Property
Back
Technology
Patent Portfolio
Publications
Species Specific Culture Medium
Pipeline
Folder: Company
Back
Leadership
Board
Contact
News

1. MSC-rich Neo-Islets control autoimmune T1DM in NOD mice_PMC5689775 (7_6_2017)

2. Neo-Islet therapy for diabetes mellitus in pet dogs - 6 months readout _PMC6752848 (9_19_2019)

3. Human Neo-Islets control diabetes mellitus in NOD/SCID mice Human Neo-Islets Publication_PMC8553138 (10_28_2021)

4. Expansion of islets for use in NIs overcomes quality inconsistencies _PMC10449143 (8_24_2023)

5. 3D Organoids of Mesenchymal Stromal and Pancreatic Islet Cells Book ChapterSpringer Nature Switzerland AG (2_20_2024) 


1. 2023 ADA Poster Slides 831-P (6_1_2023)

2. 2024 ADA Poster 1508-P (6_14_2024)

3. 2024 ADA Poster 1509-P (6_14_2024)

4. ADA 2024 Allo-NIs reduce insulin need for at least 3 years in autoimmune T1D dogs 334-OR (6_14_2024)

SymbioCellTech LLC, 615 Arapeen Drive, Salt Lake City, UT, 84108, United States   801.503.3990 or 801.643.5970   t.manning@symbocelltech.com

COPYRIGHT © 2019 - SymbioCellTech, LLC.